Recombinant Canine IL-4 Protein 754-CL-025 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Canine IL-4 Protein
CompanyR&D Systems, a Bio-Techne Brand
Price $474.00Supplier Page View Company Product Page
Catalog Number754-CL-025
SpeciesCanine
Size25 ug
Molecule NameIL-4
Source/Expression SystemE. coli-derived Recombinant Canine IL-4 Protein
FormatLyophilized from a 0.2 µm filtered solution in PBS with BSA as a carrier protein
Purity>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecular Weight12.9 kDa
ApplicationsBioactivity
Conjugate/TagUnconjugated
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene Nameinterleukin 4
NCBI Gene AliasesIL-4

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(2) Characterization of polarization states of canine monocyte derived macrophagesPloS oneJanuary 1, 2023Lyu Q, Veldhuizen EJA, Ludwig IS, Rutten VPMG, van Eden W, Sijts AJAM, Broere F.

(7) Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcomaCancer gene therapySeptember 1, 2019Konduri V, Halpert MM, Baig YC, Coronado R, Rodgers JR, Levitt JM, Cerroni B, Piscoya S, Wilson N, DiBernardi L, et al.

(8) A DNA telomerase vaccine for canine cancer immunotherapyOncotargetMay 21, 2019Thalmensi J, Pliquet E, Liard C, Chamel G, Kreuz C, Bestetti T, Escande M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, et al.

(9) Brucella canis induces canine CD4⁺ T cells multi-cytokine Th1/Th17 production via dendritic cell activationComparative immunology, microbiology and infectious diseasesFebruary 1, 2019Pujol M, Borie C, Montoya M, Ferreira A, Vernal R.

(10) Canine IL4-10 fusion protein provides disease modifying activity in a canine model of OA; an exploratory studyPloS oneJanuary 1, 2019van Helvoort EM, Popov-Celeketic J, Eijkelkamp N, Coeleveld K, Tryfonidou MA, Wijne CD, Hack CE, Lafeber FPJG, Mastbergen SC.

(11) Immunogenic potential of three transmissible venereal tumor cell lysates to prime canine-dendritic cells for cancer immunotherapyResearch in veterinary scienceDecember 1, 2018Hernández-Granados AJ, Franco-Molina MA, Coronado-Cerda EE, Zapata-Benavides P, Gamboa EM, Ramos-Zayas Y, Santana-Krímskaya SE, Rodríguez-Padilla C.

(12) Morphologic, phenotypic, and transcriptomic characterization of classically and alternatively activated canine blood-derived macrophages in vitroPloS oneJanuary 1, 2017Heinrich F, Lehmbecker A, Raddatz BB, Kegler K, Tipold A, Stein VM, Kalkuhl A, Deschl U, Baumgärtner W, Ulrich R, et al.

(14) Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-ChallengePloS oneJanuary 1, 2016Resende LA, Aguiar-Soares RD, Gama-Ker H, Roatt BM, Mendonça LZ, Alves ML, Silveira-Lemos Dd, Corrêa-Oliveira R, Martins-Filho OA, Araújo MS, et al.

(15) One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasisBMC veterinary researchApril 11, 2015Costa-Pereira C, Moreira ML, Soares RP, Marteleto BH, Ribeiro VM, França-Dias MH, Cardoso LM, Viana KF, Giunchetti RC, Martins-Filho OA, et al.

(17) Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trialPloS oneJune 11, 2010Xiong W, Candolfi M, Liu C, Muhammad AK, Yagiz K, Puntel M, Moore PF, Avalos J, Young JD, Khan D, et al.

(18) Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation modelExperimental hematologyJanuary 1, 2009Lange S, Altmann S, Brandt B, Adam C, Riebau F, Vogel H, Weirich V, Hilgendorf I, Storb R, Freund M, et al.

(19) RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphomaGene therapyJuly 1, 2008Mason NJ, Coughlin CM, Overley B, Cohen JN, Mitchell EL, Colligon TA, Clifford CA, Zurbriggen A, Sorenmo KU, Vonderheide RH.

Recombinant Canine IL-4 Protein from R&D Systems, a Bio-Techne Brand